News Briefs Biotech company Inversago Pharma raises $70m in Series C financing New Enterprise Associates led the round. Iris Dorbian - 17 October 2022 Share A- A+ 100% Create an account to continue reading Gain instant access to our expert editorial analysis and in-depth insight. Register for free Already have an account? Sign in
